Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4447614
Max Phase: Preclinical
Molecular Formula: C15H15N5O
Molecular Weight: 281.32
Molecule Type: Unknown
Associated Items:
ID: ALA4447614
Max Phase: Preclinical
Molecular Formula: C15H15N5O
Molecular Weight: 281.32
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1n[nH]c(NCc2ccccc2Oc2ccccc2)n1
Standard InChI: InChI=1S/C15H15N5O/c16-14-18-15(20-19-14)17-10-11-6-4-5-9-13(11)21-12-7-2-1-3-8-12/h1-9H,10H2,(H4,16,17,18,19,20)
Standard InChI Key: OQWJPOYPRUFCOO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 281.32 | Molecular Weight (Monoisotopic): 281.1277 | AlogP: 2.79 | #Rotatable Bonds: 5 |
Polar Surface Area: 88.85 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.51 | CX Basic pKa: 3.79 | CX LogP: 2.82 | CX LogD: 2.82 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.67 | Np Likeness Score: -1.20 |
1. Holshouser S, Dunworth M, Murray-Stewart T, Peterson YK, Burger P, Kirkpatrick J, Chen HH, Casero RA, Woster PM.. (2019) Dual inhibitors of LSD1 and spermine oxidase., 10 (5): [PMID:31191868] [10.1039/C8MD00610E] |
Source(1):